Skip to main content

Clinical trial STRIVE

a phase 2, multicenter, randomized, double-blind study of the safety, tolerability and efficacy of intravenous CD101 vs intravenous caspofungin followed by oral fluconazole stept-down in the treatment of subjects with candidemia

Cancers
Organ all types
Trial status Trial open for recruitment
Investigator
Trial type
interventional with IMP
Phase Trial phase 2
Academic trial Non
Sponsor CIDARA
EudraCT Identifier 2015-005599-51
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/study/NCT02734862
Inclusion criteria mycological diagnosis of candidemia
Last update

Follow us!

Support research

Support research

Research at the Institut Jules Bordet depends on your generosity. Make a donation today and join us in the fight against cancer.

Learn more